Get an alert when IOMET PHARMA LTD. files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Cash

£8.6m

+4% highest in 3 filed years

Net assets

£8.6m

+4.1% highest in 3 filed years

Employees

0

Average over period

Profit before tax

£342k

-3.1% lowest in 3 filed years

Accounts

3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31

Metric Trend 2023-12-312024-12-312025-12-31 Δ vs prior
Turnover
Operating profit -£23,178-£29,286-£7,063 +75.9%
Profit before tax £355,817£352,524£341,566 -3.1%
Net profit £355,817£352,524£341,566 -3.1%
Cash £8,067,462£8,287,815£8,620,033 +4%
Total assets less current liabilities £7,940,903£8,293,427£8,634,993 +4.1%
Net assets £7,940,903£8,293,427£8,634,993 +4.1%
Equity £7,940,903£8,293,427£8,634,993 +4.1%
Average employees 000
Wages
Directors' remuneration £0£0£0

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show . About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-312025-12-31
Return on capital employed -0.3%-0.4%-0.1%
Current ratio 50.23x
Interest cover -95.78x-1.19x-77.62x

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Name history

Renamed 2 times since incorporation

  1. IOMET PHARMA LTD. 2014-08-19 → present
  2. TPP GLOBAL DEVELOPMENT LIMITED 2010-04-15 → 2014-08-19
  3. CAMVO 195 LIMITED 2010-04-09 → 2010-04-15

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
PricewaterhouseCoopers LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“Given the matters described above, the Directors believe that the Company has the resources required to settle all liabilities as they fall due for at least 12 months from the date of signing the financial statements and that no material uncertainties exist. Accordingly, the financial statements have been prepared on a going concern basis.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

2 active · 15 resigned

Name Role Appointed Born Nationality
CAN TEMUCIN, Ebru Director 2018-07-18 Oct 1972 Turkish
ROGERS, Martin Ian Director 2018-07-18 Jun 1968 British
Show 15 resigned officers
Name Role Appointed Resigned
DAVIES, Amy Secretary 2020-11-23 2022-05-03
ROBINSKI, Richard Secretary 2016-01-11 2020-11-23
BROWN, Thomas James, Dr Director 2010-04-09 2016-01-11
CHRISTIAN, Don Director 2010-04-22 2016-01-11
HALSE, Reza Director 2016-01-11 2018-06-21
MARSHALL, Fiona Hamilton Director 2018-06-01 2018-10-08
MCNEILL, John Reilly Director 2016-01-11 2018-10-08
O'HAGAN, Ronan Connolly Director 2017-01-10 2018-06-01
O'KANE, Sharon, Dr Director 2010-04-22 2016-01-11
PATEL, Rakesh Jayantilal Director 2015-04-14 2016-01-11
RUILE, Stefan Director 2010-04-22 2012-01-31
TRILL, Peter Director 2010-04-09 2016-01-11
WALKER, Michael Director 2010-04-22 2016-01-11
WERNER, Michael Leopold, Dr Director 2012-03-02 2016-01-11
WISE, Alan Director 2015-09-23 2018-07-16

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Merck & Co., Inc. Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Active

Filing timeline

Last 20 of 103 total filings

Date Type Category Description
2026-07-22 AP01 officers Appoint person director company with name date PDF
2026-07-21 TM01 officers Termination director company with name termination date PDF
2026-07-10 AA accounts Accounts with accounts type full
2026-04-15 CS01 confirmation-statement Confirmation statement with no updates PDF
2026-04-15 CH01 officers Change person director company with change date PDF
2025-09-10 AA accounts Accounts with accounts type full
2025-04-15 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-09-18 AA accounts Accounts with accounts type full
2024-04-11 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-09-20 AA accounts Accounts with accounts type full
2023-04-11 CS01 confirmation-statement Confirmation statement with updates PDF
2022-08-22 AA accounts Accounts with accounts type full
2022-06-09 PSC05 persons-with-significant-control Change to a person with significant control PDF
2022-05-03 TM02 officers Termination secretary company with name termination date PDF
2022-04-20 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-08-25 AA accounts Accounts with accounts type full
2021-04-19 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-04-16 CH01 officers Change person director company with change date PDF
2021-04-16 CH01 officers Change person director company with change date PDF
2021-04-13 CH03 officers Change person secretary company with change date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
6

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page